UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Operating Activities:
Net income (loss)	$ 3,424	$ (39,797)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Non-cash lease expense	362	416
Depreciation and amortization	564	399
Stock-based compensation	1,357	810
Provision for uncollectible accounts		2,885
Unrealized exchange (gain) or loss	373	49
Provision for inventory	369	469
Change in fair value of warrant liabilities	(4,507)	1,679
Change in fair value of derivative liabilities	(1,895)	35
Change in fair value of Revenue Interest Financing and PIPE Conversion Option	(1,496)
Change in fair value of earn-out liabilities	(19,880)
Interest paid on debt recorded at fair value	(1,054)
Change in fair value of debt	(8,230)	(2,257)
Debt issuance costs associated with debt recorded at fair value	1,357
Non-cash interest expense	1,464	775
Non-cash termination of convertible note side letters		6,632
Loss on term loan extinguishment	8,713	0
Changes in operating assets and liabilities:
Accounts receivable	4,412	930
Inventory	1,014	(1,468)
Prepaid expenses, other current and long-term assets	718	634
Lease liabilities	(411)	(391)
Accounts payable	(2,504)	5,021
Accrued expenses and other current liabilities	(1,713)	3,162
Net cash used in operating activities	(17,563)	(20,017)
Investing Activities:
Purchases of property and equipment	(539)	(408)
Net cash used in investing activities	(539)	(408)
Financing Activities:
Proceeds from issuance of convertible notes	48,000	19,550
Proceeds from option and warrant exercises	26	61
Proceeds from equity line financing	378
Repayment of convertible notes		(500)
Payment of deferred financing costs		(1,604)
Payment of debt issuance costs	(1,357)
Net cash provided by financing activities	(673)	17,507
Net increase (decrease) in cash and cash equivalents and restricted cash	(18,775)	(2,918)
Cash and cash equivalents and restricted cash at beginning of period	38,421	8,023
Cash and cash equivalents and restricted cash at end of period	19,646	5,105
Supplemental disclosure of cash flow information
Cash paid for interest	2,672	3,967
Supplemental cash flow information on non-cash investing and financing activities
Purchase of property and equipment included in accounts payable	31	165
Deferred financing costs in accounts payable and accrued expenses	1,207	$ 6,918
Change in fair value of Revenue Interest Financing through OCI	(5,280)
Fortress Term Loan
Financing Activities:
Repayment of Term Loan	$ (47,720)